Showing results (1131-1140 of 1,149) with videos related to
Sort By:
Pageof 115
Journal of Hepatocellular Carcinoma|August 18, 2026
Real-World Study of Post-Recurrence Treatment Strategies for Microvascular Invasion-Positive Hepatocellular Carcinoma After Curative ResectionXiao Liu, Xiaokun Chen, Ziyue Huang, et al.Journal of Hepatocellular Carcinoma|August 17, 2026
Neoadjuvant Hepatic Arterial Infusion Chemotherapy with FOLFOX Plus Tislelizumab for Resectable Hepatocellular Carcinoma Beyond the Milan Criteria: Efficacy, Safety and Biomarker ExplorationQuanwei Dai, Huiting Deng, Jun Wang, et al.Journal of Hepatocellular Carcinoma|September 25, 2026
Large Language Models for Preoperative Microvascular Invasion Prediction in Hepatocellular Carcinoma: A Multicenter Comparison with Radiologists and Treatment OutcomesRu Wen, Xuefeng Li, Fengxi Chen, et al.Journal of Hepatocellular Carcinoma|September 14, 2026
Pre-TACE CK-MB/CK Ratio as an Independent Prognostic Biomarker in Advanced Hepatocellular CarcinomaWeiguo Lu, Ying Lu, Yang WangJournal of Hepatocellular Carcinoma|September 14, 2026
Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry DatabaseWoo-Hyoung Kang, Shin Hwang, I-Ji Jeong, et al.Journal of Hepatocellular Carcinoma|August 24, 2026
Intratumoral Para-Toluenesulfonamide (PTS) Injection for Recurrent Hepatocellular Carcinoma Adjacent to the Heart: A Case ReportChia-Ling Chiang, Chien-Yang Liao, Mao-Yuan Lin, et al.Journal of Hepatocellular Carcinoma|August 27, 2026
Efficacy Analysis of Capsule Integrity and TACE Combined with Microwave Ablation versus Microwave Ablation Alone for Primary Hepatocellular CarcinomaYang Fang, Zhongke Yan, Zhezhu Han, et al.Journal of Hepatocellular Carcinoma|October 13, 2026
Machine Learning Model Integrating Conventional Ultrasound Radiomics and Clinicopathological Features for Early Recurrence Risk Prediction After Curative-Intent Hepatectomy in Hepatocellular CarcinomaXinyue Zhao, Bolin Wu, Yichi Chen, et al.Journal of Hepatocellular Carcinoma|October 14, 2026
Discontinuing Immune Checkpoint Inhibitor-Based Therapy After Complete Response in Unresectable Hepatocellular Carcinoma: Evidence, Bias, and a Research FrameworkYujia He, Zhe WangJournal of Hepatocellular Carcinoma|October 8, 2026
Validation of the Up7-ALBI Score for Prognostication in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus BevacizumabChien-Hung Lu, Wei-Yu Kao, Yao-Yu Hsieh, et al.Pageof 115